Home Business Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

67
0
Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Gilead Sciences will acquire biotech company Immunomedics in a $21 billion deal that will expand Gilead’s availability of cancer treatments, the companies announced on Sunday. 
The deal will provide…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here